• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Packaging Technology

    Elemental Impurities: The Time Has Come

    Continuous vs. Batch Production

    2018: The evolution of pharmaceutical packaging

    Formulation Development Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Sterling Pharma Invests £6M To Expand Offerings

    Bioclinica Announces Key Hires & Promotion

    PhoenixMD, STA Enter Manufacturing Agreement

    ProBioGen, Tizona Therapeutics Enter Collaboration

    Mayne Pharma Opens $80M Oral Solid Dose Facility
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Arcinova Receives £1.5M Innovate UK Grant

    Vetter Announces Visit from Illinois Governor

    Sterling Pharma Invests £6M To Expand Offerings

    PhoenixMD, STA Enter Manufacturing Agreement

    Mayne Pharma Opens $80M Oral Solid Dose Facility
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    INTERPHEX: Adents Showcases Cloud-Based Serialization Solution

    Almac Group Expands Packaging Capabilities

    Catalent Bolsters Clinical Supply Capabilities

    West, Stevanato Group Enter Ompi EZ-fill Alliance

    Pharmaceutical Packaging Technology
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Sterling Pharma Invests £6M To Expand Offerings

    PhoenixMD, STA Enter Manufacturing Agreement

    ProBioGen, Tizona Therapeutics Enter Collaboration

    INTERPHEX: Adents Showcases Cloud-Based Serialization Solution

    SAMDI Tech Enters Drug Discovery Collaboration
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Blockchain: The Next Big Trend in BioPharma?

    Emergent Completes Market Authorization

    Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle: ICH Q12

    LSNE Expands Capabilities and QC Laboratory Space

    Evotec Launches Drug Development Service
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Dow Development Laboratories, LLC

    Avista Pharma Solutions

    Symbiosis Pharmaceutical Services

    Pfizer CentreOne Contract Manufacturing

    Rockledge Pharmaceutical Manufacturing, LLC
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    CMC Biologics, Zymeworks Enter Master Services Agreement

    CMC to provide development, clinical manufacture of antibody candidate

    Related CONTENT
    • Top Pharma Co. Extends Pact with Simulations Plus
    • CMC Biologics: Growing Through Innovation
    • CMC Biologics, IDT Biologika Partner on ADCs Services
    • CMC Biologics to Manufacture Behring’s Afstyla
    • CMC Biologics, IDT Biologika Expand Partnership
    09.03.14
    CMC Biologics, Inc. and Zymeworks Inc. have entered into a Master Services Agreement for the process development, formulation development, and cGMP clinical manufacture of a recombinant human IgG1 bi-specific (heterodimeric) antibody.
     
    "Being selected by Zymeworks, who are known for developing best-in-class and highly effective protein therapeutics, is a natural fit for us and validates our technical excellence and partnering philosophy," said Gustavo Mahler, Ph.D., global chief operations officer of CMC Biologics. "Through this agreement, Zymeworks and CMC Biologics will work together to advance the next frontier of bi-specific antibody development platforms and bring novel therapies to patients in need."
     
    "As we advance our lead Azymetric oncology program and first therapeutic built on our proprietary ZymeCAD platform, choosing a contract partner with a track record of success in development and manufacturing is critical," said Ali Tehrani, Ph.D., president and chief executive officer of Zymeworks.  "Our collaboration with CMC Biologics helps position us to move our oncology program into clinical trials for the treatment of breast cancer and other solid tumors, as well as subsequent therapeutic candidates targeted towards hematological cancers such as leukemia and lymphoma."
    Related Searches
    • Development
    • cGMP
    • Manufacturing
    • contractpharma.com
    Suggested For You
    Altor BioScience and CMC Biologics Team Up Altor BioScience and CMC Biologics Team Up
    Permira Funds Acquires LSNE Permira Funds Acquires LSNE
    AGC to Acquire CMC Biologics AGC to Acquire CMC Biologics
    Catalyst Completes Mfg. Agreements for Factor VIIa Product Catalyst Completes Mfg. Agreements for Factor VIIa Product
    CMC Biologics, IDT Biologika Expand Partnership CMC Biologics, IDT Biologika Expand Partnership
    CMC Biologics to Manufacture Behring’s Afstyla CMC Biologics to Manufacture Behring’s Afstyla
    CMC Biologics, IDT Biologika Partner on ADCs Services CMC Biologics, IDT Biologika Partner on ADCs Services
    CMC Biologics: Growing Through Innovation CMC Biologics: Growing Through Innovation
    Top Pharma Co. Extends Pact with Simulations Plus Top Pharma Co. Extends Pact with Simulations Plus

    Related Breaking News

    • Bio News | Collaborations & Alliances | Industry News
      Telix, INSERM, and ARRONAX Enter Agreement

      Telix, INSERM, and ARRONAX Enter Agreement

      To explore the feasibility of using several of Telix's clinical targeting agents with astatine
      04.16.18

    • Bio News | Collaborations & Alliances | Industry News
      Idera, Pillar Partners Enter Agreement

      Idera, Pillar Partners Enter Agreement

      Pillar Partners will provide funding to support three clinical trials to expand the clinical research of Idera's IMO-2125
      04.16.18

    • CRO News
      Pfizer Joins the TriNetX Global Research Network

      Pfizer Joins the TriNetX Global Research Network

      Aims to improve clinical trial design and accelerate drug development
      04.10.18


    • Bio News | Industry News | Trials & Filings
      FDA Grants FTD to Proteostasis Therapeutics

      FDA Grants FTD to Proteostasis Therapeutics

      For their triple combination program for the treatment of cystic fibrosis
      04.04.18

    • Bio News | Collaborations & Alliances | Industry News
      PTC, CHDI Enter Research Agreement

      PTC, CHDI Enter Research Agreement

      To advance PTC's Huntington's disease program
      04.04.18

    • Bio News | Collaborations & Alliances | Industry News
      IONTAS & IGEM Enter Collaboration

      IONTAS & IGEM Enter Collaboration

      To expand upon IGEM-F, an IgE targeting ovarian and other cancers
      04.04.18


    • CRO News
      Syneos Health Joins Align Clinical CRO

      Syneos Health Joins Align Clinical CRO

      Aims to establish new industry standards to improve clinical trial collaboration and execution
      03.27.18

    • Bio News | Collaborations & Alliances | Industry News
      Catalyst Receives $1.5M in Milestones

      Catalyst Receives $1.5M in Milestones

      After two triggering events for its neuronal nicotinic receptor (NNR) asset TC-6499
      03.26.18

    • Industry News | Trials & Filings
      AMAG Submits NDA to FDA

      AMAG Submits NDA to FDA

      For bremelanotide, for the treatment of acquired, generalized hypoactive sexual desire disorder
      03.26.18


    • Industry News
      Orkila, Lonza Enter Capsule Delivery Solutions Pact

      Orkila, Lonza Enter Capsule Delivery Solutions Pact

      Orkila to promote Capsugel capsule range in Egypt
      03.23.18

    • Bio News | Breaking News | Industry News | Trials & Filings
      Novartis Meets Primary Endpoint

      Novartis Meets Primary Endpoint

      Fom the Phase III EXPAND study of oral, once-daily siponimod (BAF312) in secondary progressive multiple sclerosis (SPMS)
      03.23.18

    • Promotions & Moves
      Rho Names New QA Director and Clinical Ops VP

      Rho Names New QA Director and Clinical Ops VP

      Lysa Triantafillou and Matt Healy bring extensive clinical research experience
      03.21.18

    • CRO News
      Synexus Expands Central and Eastern Europe Ops

      Synexus Expands Central and Eastern Europe Ops

      Opens new clinic in Czech Republic
      03.21.18

    • cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Industry News | Solid Dosage/Creams/Ointments
      Hovione Expands Capacity

      Hovione Expands Capacity

      Plans for future expansion at its sites in Portugal, Ireland and New Jersey
      03.19.18

    • Bio News | Industry News | Promotions & Moves
      PMV Pharma Appoints CMO

      PMV Pharma Appoints CMO

      Dr. Salim Yazji brings over tow decades of industry experience to the company
      03.19.18

    Breaking News
    • Sterling Pharma Invests £6M To Expand Offerings
    • AGC Chemicals to Feature Advanced Intermediates
    • Avema to Showcase Range of Services
    • Peter Stein to Deliver FDA Keynote Presentation
    • CPhI NA Conference to Focus on Fostering Innovation
    View Breaking News >
    CURRENT ISSUE

    April 2018

    • Pharmaceutical Packaging Technology
    • Elemental Impurities: The Time Has Come
    • Continuous vs. Batch Production
    • 2018: The evolution of pharmaceutical packaging
    • Formulation Development Trends
    • Changing Dynamics: The CDMO market in focus
    • Contract BioManufacturing in China: Creating a New Segment
    • View More >

    Copyright © 2018 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.